California launches massive data drive to transform early psychosis treatment
NCT ID NCT04007510
First seen Jun 26, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This study aims to create a network of clinics across California that use a mobile app to collect data from people with early psychosis and their families. The data will help doctors track symptoms and make better treatment decisions. Researchers will also develop a tool to measure how long psychosis goes untreated, which may improve early intervention. Over 1,300 participants will be followed for up to two years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
mHealth app and DUP assessment tool
What this could lead to
If successful, this could create a model for using real-world data to improve treatment planning and outcomes for people with early psychosis.
What could go wrong
This is an observational, data-gathering study, not a treatment trial. It may not directly improve symptoms, and the tools developed may not work well in all community clinics.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIRST EPISODE PSYCHOSIS (FEP) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Imaging Research Center
Sacramento, California, 95817, United States